knowledge -WSS

knowledge

author：leisure time 2025-10-01 21:12:56 - browse：8558

Christoph Lengauer stands for a portrait. -- biotech coverage from STAT — Christoph Lengauer, co-founder and CSO of Curie.Bio Vanessa Leroy for STAT

Curie.Bio, the new biotech investment firm and incubator launched earlier this year by a group of industry veterans including Alexis Borisy and Zach Weinberg, has graduated its first startup.

The startup, Forward Therapeutics, is coming out of the incubator with three drug candidates for chronic inflammatory disorders. It also just closed its first major financing round: a $50 million Series A round led by BVF Partners, with participation from RA Capital Management and OrbiMed. That money should be enough for Forward to begin clinical trials — a rare feat in the biotech world, where companies often need to raise multiple private financing rounds in order to be ready for human tests.

“Usually, with Series A money, you get a development candidate, and use Series B to take molecules to the clinic,” Forward CEO Toufike Kanouni told STAT. But with the Curie team’s help, and the $8 million in seed financing it provided, Forward was able to move much faster.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： ‘Oppenheimer’ and the risks of AI in health care

WSS

‘Oppenheimer’ and the risks of AI in health care

National panel will explore requiring free Covid tests

Scientists inch closer to single

Boston competes with Raleigh

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Wildfire pollution widens asthma inequities on Long Island

focus

knowledge

hotspot

Peter Hotez and the public health issue of online harassment

Investment in vaccine development is lagging, report finds

23andMe had bad news about my health. I wish a person had delivered it

Micronoma's microbiome cancer diagnostic approach under fire

As demand for Covid shots wanes, Moderna seeks its next success

How generative AI ratchets up security threats for health systems

At least 13 dead in Texas as scorching temps continue

Mega Millions pot grows to $1.25 billion after no winner

Anesthesiologist group: stop taking Ozempic before surgery

National panel will explore requiring free Covid tests

focus

Biogen walks away from Aduhelm, years after polarizing approval

Medicare drug price negotiation legal challenge met with skepticism

FTC sues over Novant Health acquisition of two N.C. hospitals

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

Investment in vaccine development is lagging, report finds

What the airline industry can learn from medicine

leisure time

hotspot

explore

leisure time